The Effectiveness of Conbercept Combined with Panretinal Photocoagulation vs. Panretinal Photocoagulation in the Treatment of Diabetic Retinopathy: A Meta-Analysis

Chao Huang; Haiqing Ji; Xuguang Han

doi:10.1155/2021/5591719

The Effectiveness of Conbercept Combined with Panretinal Photocoagulation vs. Panretinal Photocoagulation in the Treatment of Diabetic Retinopathy: A Meta-Analysis

J Ophthalmol. 2021 May 8:2021:5591719. doi: 10.1155/2021/5591719. eCollection 2021.

Authors

Chao Huang¹, Haiqing Ji², Xuguang Han³

Affiliations

¹ Department of Ophthalmology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
² Outpatient Department, Weifang Eye Hospital, Weifang, Shandong, China.
³ Department of Ophthalmology, Jinan Second People's Hospital, Jinan, Shandong, China.

Abstract

Objective: This meta-analysis aimed to compare the effect and safety of conbercept with panretinal photocoagulation (PRP) vs. PRP in the treatment of diabetic retinopathy (DR).

Methods: Relevant studies were identified through systemic searches of PubMed, EMBASE, China National Knowledge Infrastructure, and Wanfang database up to December 2020. The results of conbercept and PRP in patients with DR were analyzed, including overall effectiveness, best corrected visual acuity, central macular thickness, and complications.

Results: 12 articles involving 1244 patients with DR were identified for this meta-analysis. The results of the meta-analysis showed that conbercept combined with PRP significantly increased the level of overall effectiveness and significantly reduced the central thickness of macula and the incidence of complications compared with the control group.

Conclusions: Conbercept with PRP tended to be more effective than PRP alone in terms of functional outcomes for treating DR.

Publication types

Review